These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37491788)

  • 21. [Simulator sickness in the aircraft training of military and civil pilots of various types of aircraft].
    Wojciechowski P; Blaszczyk J
    Med Pr; 2019 Jun; 70(3):317-325. PubMed ID: 31162483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simulator sickness in a helicopter flight training school.
    Webb CM; Bass JM; Johnson DM; Kelley AM; Martin CR; Wildzunas RM
    Aviat Space Environ Med; 2009 Jun; 80(6):541-5; discussion 546. PubMed ID: 19522364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virtual reality sickness questionnaire (VRSQ): Motion sickness measurement index in a virtual reality environment.
    Kim HK; Park J; Choi Y; Choe M
    Appl Ergon; 2018 May; 69():66-73. PubMed ID: 29477332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cinnarizine in the prophylaxis of car sickness in children.
    Macnair AL
    Curr Med Res Opin; 1983; 8(7):451-5. PubMed ID: 6627971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance.
    Gordon CR; Gonen A; Nachum Z; Doweck I; Spitzer O; Shupak A
    J Psychopharmacol; 2001 Sep; 15(3):167-72. PubMed ID: 11565623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transdermal scopolamine, oral meclizine, and placebo in motion sickness.
    Dahl E; Offer-Ohlsen D; Lillevold PE; Sandvik L
    Clin Pharmacol Ther; 1984 Jul; 36(1):116-20. PubMed ID: 6734040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cinnarizine in the prevention of seasickness.
    Doweck I; Gordon CR; Spitzer O; Melamed Y; Shupak A
    Aviat Space Environ Med; 1994 Jul; 65(7):606-9. PubMed ID: 7945126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cinnarizine in the prophylaxis of seasickness: laboratory vestibular evaluation and sea study.
    Shupak A; Doweck I; Gordon CR; Spitzer O
    Clin Pharmacol Ther; 1994 Jun; 55(6):670-80. PubMed ID: 8004883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence, Predictors, and Prevention of Motion Sickness in Zero-G Parabolic Flights.
    Golding JF; Paillard AC; Normand H; Besnard S; Denise P
    Aerosp Med Hum Perform; 2017 Jan; 88(1):3-9. PubMed ID: 28061915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Combination of Scopolamine and Psychostimulants for the Prevention of Severe Motion Sickness.
    Zhang LL; Liu HQ; Yu XH; Zhang Y; Tian JS; Song XR; Han B; Liu AJ
    CNS Neurosci Ther; 2016 Aug; 22(8):715-22. PubMed ID: 27160425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disorientation and postural ataxia following flight simulation.
    Kennedy RS; Berbaum KS; Lilienthal MG
    Aviat Space Environ Med; 1997 Jan; 68(1):13-7. PubMed ID: 9006876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Motion sickness and cybersickness - Sensory mismatch.
    Laessoe U; Abrahamsen S; Zepernick S; Raunsbaek A; Stensen C
    Physiol Behav; 2023 Jan; 258():114015. PubMed ID: 36323375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of motion sickness in parabolic flight with buccal scopolamine.
    Norfleet WT; Degioanni JJ; Calkins DS; Reschke MF; Bungo MW; Kutyna FA; Homick JL
    Aviat Space Environ Med; 1992 Jan; 63(1):46-51. PubMed ID: 1550533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of experimental motion sickness by scopolamine absorbed through the skin.
    Graybiel A; Knepton J; Shaw J
    Aviat Space Environ Med; 1976 Oct; 47(10):1096-100. PubMed ID: 791234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time Course of Simulator Sickness in Asian Military Pilots.
    Qi Loi JE; Ling Lee ML; Chuan Tan BB; See B
    Aerosp Med Hum Perform; 2020 Nov; 91(11):892-896. PubMed ID: 33334410
    [No Abstract]   [Full Text] [Related]  

  • 36. Cinnarizine for Sea Sickness During a Remote Pacific Ocean Rescue Mission.
    Lyon RF; Rush SC; Roland T; Jethanamest D; Schawn CP; Kharod C
    J Spec Oper Med; 2015; 15(2):1-6. PubMed ID: 26125158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of a motion sickness history questionnaire for prediction of simulator sickness.
    Kennedy RS; Fowlkes JE; Berbaum KS; Lilienthal MG
    Aviat Space Environ Med; 1992 Jul; 63(7):588-93. PubMed ID: 1616434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate.
    Golding JF; Stott JR
    Br J Clin Pharmacol; 1997 Jun; 43(6):633-7. PubMed ID: 9205824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central effects of cinnarizine: restricted use in aircrew.
    Nicholson AN; Stone BM; Turner C; Mills SL
    Aviat Space Environ Med; 2002 Jun; 73(6):570-4. PubMed ID: 12056673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium antagonists in the prevention of motion sickness.
    Lee JA; Watson LA; Boothby G
    Aviat Space Environ Med; 1986 Jan; 57(1):45-8. PubMed ID: 3510617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.